Table 2.
Adjusted odds ratios for association between significant independent predictors and antibiotic prescription without documented indication
| Predictors | Adjusted odds ratio* (95% CI) |
|---|---|
| Age and sex: | |
| Males: ≥18 v <18 | 2.3 (1.02 to 5.3) |
| Females: ≥18 v <18 | 1.1 (0.6 to 2.2) |
| Chronic disease | 1.4 (0.95 to 2.2) |
| Specialty: | |
| Primary care | Reference |
| All other specialties | 2.1 (1.2 to 3.7) |
| Common prescribers† | 1.9 (1.1 to 3.3) |
| Longer visit: ≥17 min v <17 min | 1.6 (1.1 to 2.5) |
| Culture taken | 0.2 (0.1 to 0.4) |
| Antibiotic class: | |
| Penicillins | Reference |
| Cephalosporins | 1.6 (0.96 to 2.7) |
| Macrolides | 0.9 (0.4 to 2.1) |
| Miscellaneous | 1.6 (0.8 to 3.2) |
| Other‡ | 1.3 (0.7 to 2.5) |
| Quinolones | 1.5 (0.8 to 2.7) |
| Sulfonamides | 4.9 (1.5 to 15.7) |
| Tetracyclines | 1.3 (0.6 to 2.7) |
| Urinary anti-infectives | 3.1 (1.3 to 7.6) |
Adjusted for age, sex, geographic region, and pre-surgery visit.
Includes specialists in gynecology, urology, dermatology, and otolaryngology.
Includes carbapenems, leprostatics, aminoglycosides, lincomycin derivatives, glycylcyclines, and glycopeptide antibiotics.